Kalvista Pharmaceuticals Inc
General ticker "KALV" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $434.2M
Kalvista Pharmaceuticals Inc does not follow the US Stock Market performance with the rate: -15.3%.
Estimated limits based on current volatility of 4.0%: low 8.12$, high 8.80$
Factors to consider:
- Price in estimated range
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-04-30 to 2026-04-30
- 2024-04-30 to 2025-04-30 estimated range: [8.39$, 18.63$]
- 2025-04-30 to 2026-04-30 estimated range: [7.55$, 17.05$]
Financial Metrics affecting the KALV estimates:
- Negative: Non-GAAP EPS, $ of -3.40 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: Operating cash flow per share per price, % of -17.55 <= 2.35
- Negative: negative Net income
- Positive: Interest expense per share, $ of 0 <= 0
- Positive: -3.48 < Investing cash flow per share, $ of -2.30
Short-term KALV quotes
Long-term KALV plot with estimates
Financial data
| YTD | 2022-04-30 | 2023-04-30 | 2024-04-30 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $96.61MM | $110.87MM | $140.44MM |
| Operating Income | $-96.61MM | $-110.87MM | $-140.44MM |
| Non-Operating Income | $14.27MM | $17.96MM | $5.35MM |
| Interest Expense | $1.09MM | $0.00MM | $0.00MM |
| R&D Expense | $70.17MM | $80.28MM | $86.17MM |
| Income(Loss) | $-82.34MM | $-92.91MM | $-135.10MM |
| Taxes | $0.00MM | $0.00MM | $-8.45MM |
| Profit(Loss) | $-82.34MM | $-92.91MM | $-126.64MM |
| Stockholders Equity | $185.09MM | $161.03MM | $206.58MM |
| Inventory | $2.71MM | $0.00MM | $0.00MM |
| Assets | $203.88MM | $183.20MM | $235.40MM |
| Operating Cash Flow | $-78.13MM | $-75.26MM | $-89.23MM |
| Capital expenditure | $0.93MM | $1.20MM | $0.44MM |
| Investing Cash Flow | $57.86MM | $41.41MM | $-84.72MM |
| Financing Cash Flow | $1.58MM | $58.12MM | $150.71MM |
| Earnings Per Share* | $-2.80 | $-2.68 | $-3.44 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.